MedWatch

Financier aims to attract foreign investors to Danish biotech companies

Wealthy foreigners are keen on investing in promising Danish life science companies. This is according to Martin Rasmussen, who has 25 years of experience in London's investment banks and convinced a British family to invest in Copenhagen-based Immunitrack.

On behalf of Immunitrack, Martin Rasmussen contacted a British wealthy family that invested millions in teh company. | Foto: Niels Ahlmann Olesen/Ritzau Scanpix

When Danish biotech company and CRO Immunitrack received a million investment in May this year, the money came from an unknown wealthy Londoner whose key competence is actually not life science.

The untraditional investor got involved after a common friend introduced the company to a London-based Dane called Martin Rasmussen, who made it his business to convince the city's wealthy families of investing in Danish life science.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Selvtests til skoleelever er på lager – nyt udbud sat i gang

Der ligger antigentests klar på lager fra tidligere indkøb, og de dækker i første omgang behovet for selvtests til skoleelever, som Regeringen og KL forleden besluttede skal supplere de kommunale skolers testindsats. En nyt udbud er netop skudt i gang for at dække efterspørgslen, når lagrene er tømte, oplyser styrelse.

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier